
ImmunityBio, Inc.
IBRXNasdaqCIK 1326110HealthcareFiscal year ends Dec 31
Reports and events: 180 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-08-1208:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001326110-24-000103 |
| 2024-07-1821:48 ET | 8-K | 1.01 Entry into a material agreement | 0001326110-24-000093 |
| 2024-06-1216:36 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001326110-24-000069 |
| 2024-05-0917:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001326110-24-000064 |
| 2024-04-2916:18 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0001326110-24-000054 |
| 2024-04-2306:17 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-24-000040 |
| 2024-03-1916:31 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001326110-24-000037 |
| 2024-02-2621:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.05 Item not in the standard list | 0001193125-24-044886 |
| 2024-01-0421:59 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-001705 |
| 2024-01-0206:08 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-24-000003 |
| 2023-11-0921:28 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001326110-23-000147 |
| 2023-09-2116:25 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-239612 |
| 2023-09-1106:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-23-000121 |
| 2023-09-0108:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-23-000112 |
| 2023-08-1516:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-23-000102 |
| 2023-08-0816:15 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001326110-23-000098 |
| 2023-07-2106:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-190800 |
| 2023-07-2016:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-190491 |
| 2023-06-1417:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001326110-23-000076 |
| 2023-05-2319:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-150724 |
| 2023-05-1106:47 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001326110-23-000064 |
| 2023-05-1106:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-23-000063 |
| 2023-04-2816:24 ET | DEF 14A | Proxy statement | 0001326110-23-000050 |
| 2023-03-3116:29 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001326110-23-000028 |
| 2023-03-2008:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-23-000023 |
| 2023-03-0117:18 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001326110-23-000018 |
| 2023-02-1509:20 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-039833 |
| 2023-02-1417:25 ET | 8-K | 2.02 Results of operations | 0001193125-23-039399 |
| 2023-02-1308:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-23-000014 |
| 2022-12-1209:07 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-302356 |
| 2022-12-0720:28 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-22-299573 |
| 2022-12-0510:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-22-000076 |
| 2022-11-1508:42 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-285314 |
| 2022-11-0920:52 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001326110-22-000074 |
| 2022-09-0216:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001326110-22-000064 |
| 2022-08-0816:45 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001326110-22-000058 |
| 2022-06-1416:59 ET | 8-K | 5.07 Shareholder vote results | 0001326110-22-000038 |
| 2022-05-1016:08 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001326110-22-000027 |
| 2022-04-2916:11 ET | DEF 14A | Proxy statementPeriod 2022-06-14 | 0001193125-22-133671 |
| 2022-03-2517:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-085325 |
| 2022-03-0117:03 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001326110-22-000011 |
| 2022-02-1509:00 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-042967 |
| 2022-01-1208:35 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-007333 |
| 2021-12-2009:07 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-361818 |
| 2021-11-1216:38 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001326110-21-000009 |
| 2021-09-2708:46 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-21-283078 |
| 2021-09-1308:37 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-270970 |
| 2021-08-1316:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-246082 |
| 2021-08-1216:29 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-044008 |
| 2021-06-1507:11 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-190551 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.